Billiontoone (NASDAQ:BLLN) Trading Up 9.4% – Should You Buy?

Billiontoone, Inc. (NASDAQ:BLLN)’s share price rose 9.4% during mid-day trading on Monday . The company traded as high as $94.75 and last traded at $94.00. Approximately 77,762 shares changed hands during trading, a decline of 62% from the average daily volume of 202,329 shares. The stock had previously closed at $85.94.

Wall Street Analysts Forecast Growth

BLLN has been the subject of a number of recent analyst reports. BTIG Research reiterated a “buy” rating and issued a $160.00 price target on shares of Billiontoone in a research report on Wednesday, December 10th. Wells Fargo & Company started coverage on shares of Billiontoone in a research note on Monday, December 1st. They set an “equal weight” rating and a $110.00 price objective for the company. Guggenheim started coverage on shares of Billiontoone in a research report on Tuesday, January 6th. They issued a “buy” rating and a $120.00 target price on the stock. William Blair initiated coverage on shares of Billiontoone in a research report on Monday, December 1st. They issued an “outperform” rating for the company. Finally, Piper Sandler reissued an “overweight” rating on shares of Billiontoone in a research note on Wednesday, December 10th. Six equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $135.29.

Billiontoone Stock Performance

The stock’s 50 day moving average price is $99.86. The stock has a market cap of $4.54 billion and a PE ratio of 991.50.

Billiontoone (NASDAQ:BLLN) last announced its quarterly earnings results on Tuesday, December 9th. The company reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.16 by ($0.06). The firm had revenue of $83.52 million during the quarter, compared to analyst estimates of $82.86 million.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Billiontoone stock. Green Alpha Advisors LLC acquired a new stake in Billiontoone, Inc. (NASDAQ:BLLN) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 5,326 shares of the company’s stock, valued at approximately $436,000.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.